Journal
CELL CYCLE
Volume 9, Issue 15, Pages 3085-3099Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/cc.9.15.12521
Keywords
PML; genotoxic stress; JAK/STAT signaling; interferons; DNA damage; cellular senescence; p53; tumor suppressor; cytokines
Categories
Funding
- Grant Agency of the Academy of Sciences of the Czech Republic [IAA500390501]
- Grant Agency of the Czech Republic [204/08/1418, 301/08/0353]
- Institutional Grant [AV0Z5039906]
- Danish Cancer Society
- Danish National Research Foundation
- Czech Ministry of Education [MSM6198959216]
- Novo Nordisk [R153-A12997]
- European Commission
Ask authors/readers for more resources
The Promyelocytic leukemia protein (PML) tumor suppressor is upregulated in several forms of cellular senescence, however the mechanism of its induction is elusive. Here we show that genotoxic drugs that induce senescence, such as 5-bromo-2'deoxyuridine (BrdU), thymidine (TMD), distamycin A (DMA), aphidicolin (APH), etoposide (ET) and camptothecin (CPT) all evoke expansion of PML nuclear compartment and its association with persistent DNA lesions in several human cancer cell lines and normal diploid fibroblasts. This phenomenon was accompanied by elevation of PML transcripts after treatment with BrdU, TMD, DMA and CPT. Chemical inhibition of all JAK kinases and RNAi-mediated knock-down of JAK1 suppressed PML expression, implicating JAK/STAT-mediated signaling in regulation of the PML gene. As PML protein stability remained unchanged after drug treatment, decreased protein turnover was unlikely to explain the senescence-associated increased abundance of PML. Furthermore, binding activity of Interferon Stimulated Response Element (ISRE) within the PML gene promoter, and suppression of reporter gene activity after deletion of ISRE from the PML promoter region suggested that drug-induced PML transcription is controlled via transcription factors interacting with this element. Collectively, our data show that upregulation of the PML tumor suppressor in cellular senescence triggered by diverse drugs including clinically used anti-cancer chemotherapeutics relies on stimulation of PML transcription by JAK/STAT-mediated signaling, possibly evoked by the autocrine/paracrine activities of senescence-associated cytokines.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available